Women's Health
What Causes High AMH in Women?
Most women hear that higher AMH is better — more eggs, more time. But when AMH climbs above the reference range, it can signal polycystic ovary syndrome, insulin resistance, or an overstimulated ovarian response. Understanding what's driving the number matters more than the number itself.
What Causes High AMH in Women?
High AMH is usually a sign of a larger-than-average antral follicle pool, most commonly due to polycystic ovary syndrome (PCOS). For the majority of women with elevated AMH, the root driver is insulin resistance or excess androgens — not a simple surplus of healthy fertility. The exception is women undergoing ovarian stimulation monitoring or adolescents, where naturally high AMH is expected and rarely pathological.
---
What Is AMH and What Does "High" Actually Mean?
Anti-Müllerian hormone (AMH) is produced by granulosa cells in small, growing ovarian follicles. It serves as a proxy for ovarian reserve — essentially, how many recruitable follicles remain. Reference ranges vary slightly by lab, but most use the following benchmarks for women of reproductive age:
| Age Range | Low AMH (ng/mL) | Normal AMH (ng/mL) | High AMH (ng/mL) |
|---|---|---|---|
| 20–29 | < 1.0 | 1.5 – 3.5 | > 3.5 |
| 30–34 | < 0.8 | 1.2 – 3.0 | > 3.0 |
| 35–39 | < 0.5 | 0.8 – 2.5 | > 2.5 |
| 40+ | < 0.3 | 0.5 – 1.5 | > 1.5 |
AMH does not fluctuate significantly across the menstrual cycle, which makes it a reliable standalone test — but context from FSH, LH, estradiol, and ultrasound antral follicle count still matters for interpretation (La Marca et al., Human Reproduction Update 2009; PMID: 19091784).
For context on how other hormones interact with this picture, the overview of what causes low Anti-Müllerian hormone in women covers the opposite end of the spectrum and can help frame what a normal trajectory looks like.
---
The Most Common Cause: PCOS and Follicular Excess
Polycystic ovary syndrome accounts for the large majority of clinically elevated AMH readings in women of reproductive age. In PCOS, small antral follicles accumulate rather than being recruited normally into a dominant follicle each cycle. Each of those arrested follicles continues secreting AMH, and the cumulative output can push levels two to four times above the upper reference limit.
A meta-analysis of 19 studies found that AMH levels in women with PCOS were on average 2.9-fold higher than in age-matched controls, with the elevation correlating most strongly with antral follicle count (Iliodromiti et al., Human Reproduction 2013; PMID: 23528323). This makes AMH one of the most sensitive biomarkers for distinguishing PCOS from other causes of oligomenorrhea — more so than LH:FSH ratio in some studies.
Why do follicles arrest in PCOS? The prevailing mechanism involves androgen excess. Elevated testosterone and androstenedione promote early follicle recruitment but impair the normal selection of a dominant follicle. AMH itself appears to amplify this dysfunction: it suppresses FSH sensitivity in granulosa cells, which further reduces the chance any follicle reaches ovulation (Dewailly et al., Human Reproduction Update 2016; PMID: 26932840).
This creates a reinforcing loop — more follicles → more AMH → less FSH responsiveness → more follicle accumulation.
---
Insulin Resistance as a Fuel Source
Insulin resistance doesn't just co-exist with PCOS — it actively drives AMH elevation. Hyperinsulinemia stimulates ovarian theca cells to overproduce androgens, and those androgens promote follicular arrest. In a study of 244 women with PCOS, fasting insulin was independently associated with AMH levels after controlling for BMI and age (Piouka et al., European Journal of Endocrinology 2009; PMID: 19174534).
This is why AMH should not be reviewed in isolation. If your AMH is elevated, checking what causes high fasting insulin in women is a logical next step — the two biomarkers often move together and respond to overlapping interventions.
Women with elevated AMH driven by insulin resistance frequently report irregular cycles, difficulty losing weight around the midsection, and skin changes like acanthosis nigricans. These are not fertility metrics — they are metabolic warning signals that extend well beyond the ovary.
---
Other Causes of High AMH Worth Ruling Out
PCOS and insulin resistance are the dominant drivers, but they are not the only ones. A thorough differential includes:
- Granulosa cell tumors: Rare ovarian tumors that secrete AMH autonomously. AMH can rise dramatically — sometimes above 100 ng/mL — and is used as a tumor marker in this context. Always rule out malignancy when AMH is extremely elevated without evidence of polycystic ovarian morphology.
- Adolescent physiology: AMH peaks in the late teens to early twenties. Values above 3.5–4.0 ng/mL in a 17–22-year-old may reflect normal physiology rather than pathology.
- Ethnic variation: Studies have shown that women of Black and Hispanic ethnicity have modestly higher AMH levels at baseline compared to white women of the same age, likely reflecting differences in antral follicle density (Seifer et al., Fertility and Sterility 2009; PMID: 18930228).
- Ovarian hyperstimulation risk: In IVF contexts, high AMH predicts exaggerated response to gonadotropin stimulation and elevates risk of ovarian hyperstimulation syndrome (OHSS). Reproductive endocrinologists routinely adjust protocols — typically using lower FSH starting doses or antagonist protocols — when AMH exceeds 3.0–3.5 ng/mL.
- Thyroid dysfunction: Subclinical hypothyroidism has been associated with modest AMH elevation in some observational data, though the mechanism is not fully established. If TSH is trending high, reviewing what causes high TSH in women alongside AMH context is worthwhile.
---
What High AMH Means for Fertility
Here is where nuance matters most. High AMH is often reflexively celebrated as "great ovarian reserve" — but this framing misses critical context.
For women without PCOS, a higher AMH within the upper-normal range genuinely does correlate with more available cycles, a longer reproductive window, and better IVF egg yield. This is the population where the "more is better" interpretation holds.
For women with PCOS-driven AMH elevation, the story is different. Despite having large follicle counts, ovulation is irregular or absent. Natural conception rates may be lower, not higher. IVF outcomes per retrieved egg are often comparable to or slightly below age-matched controls because egg quality — not quantity — is the limiting factor. A 2019 systematic review found that while PCOS patients produce more oocytes per retrieval cycle, live birth rates per transfer are not significantly superior and may be complicated by higher miscarriage rates in those with concurrent insulin resistance (Homburg et al., Reproductive BioMedicine Online 2019).
The distinction matters practically: a woman with an AMH of 5.2 ng/mL who ovulates regularly and has no androgen excess has a different prognosis than a woman with the same AMH, anovulation, and a fasting insulin of 18 µIU/mL.
---
Lifestyle and Nutritional Factors That Influence AMH
AMH is more modifiable than many practitioners suggest. Several nutritional and lifestyle interventions show meaningful effects:
1. Reducing Refined Carbohydrates and Glycemic Load
Lowering dietary glycemic load reduces fasting insulin, which reduces androgen-driven follicular arrest. A 16-week dietary intervention in 28 women with PCOS showed significant reductions in testosterone and AMH with a low-glycemic diet compared to a standard healthy-eating control (Douglas et al., Applied Physiology, Nutrition and Metabolism 2006).
2. Resistance Training
Skeletal muscle is the primary site of glucose disposal. Increasing muscle mass through resistance exercise improves insulin sensitivity, which secondarily lowers androgen production. Two to three sessions per week of progressive resistance training is a first-line behavioral intervention for PCOS.
3. Vitamin D Repletion
Vitamin D deficiency is significantly more prevalent in women with PCOS than in controls. Vitamin D receptors are expressed in granulosa cells, and vitamin D supplementation has been associated with modest reductions in AMH in vitamin D-deficient women with PCOS (Irani & Merhi, European Journal of Obstetrics & Gynecology 2014; PMID: 24998401).
4. Inositol (Myo-Inositol and D-Chiro-Inositol)
Myo-inositol is an insulin sensitizer with specific affinity for ovarian tissue. Multiple randomized trials have shown improvements in insulin sensitivity, testosterone, and AMH levels in PCOS over 12–24 weeks. It is one of the few supplements with a well-characterized mechanism and consistent replication in PCOS trials.
5. Inflammation Management
Chronic low-grade inflammation, often reflected in elevated high-sensitivity CRP, contributes to PCOS pathophysiology. Anti-inflammatory dietary patterns — higher in omega-3 fatty acids, polyphenols, and fiber — are associated with improved hormonal profiles in observational studies.
---
What This Means for Your Formula
When AMH is elevated in the context of PCOS or insulin resistance, the supplement protocol needs to address the upstream drivers — androgen excess, insulin signaling dysfunction, and inflammation — not the AMH number itself.
Ones builds personalized formulas using lab data and health history, and for women with hormonal imbalance patterns consistent with PCOS or insulin-driven androgen excess, the formula may include:
- Omega-3 (EPA/DHA): Clinical doses of EPA and DHA reduce circulating triglycerides and have demonstrated anti-inflammatory effects in ovarian tissue. Ones sources pharmaceutical-grade fish oil dosed to the EPA/DHA ratios used in PCOS trials.
- Vitamin D3 + K2 (MK-7): Vitamin D deficiency is a consistent finding in PCOS populations, and repletion to optimal serum levels (50–80 ng/mL) is associated with improved insulin sensitivity and hormonal markers. Ones pairs D3 with MK-7 to support vascular handling of calcium mobilized by higher D3 doses.
- Ones Endocrine Support blend: This proprietary system support is designed for women with hormonal dysregulation patterns. It complements individual active ingredients by addressing adrenal-ovarian crosstalk — relevant because cortisol dysregulation can amplify androgen excess in PCOS.
If your labs include elevated fasting insulin alongside high AMH, Ones' AI health practitioner will flag this pattern and calibrate your capsule formula accordingly — addressing metabolic drivers rather than focusing on a single number in isolation.
---
Key Takeaways
- High AMH most commonly signals PCOS, driven by follicular arrest from androgen excess and insulin resistance — not simply an abundance of healthy eggs.
- The same AMH number means different things depending on whether cycles are regular and androgens are in range; always interpret AMH alongside fasting insulin, androgens, and ultrasound.
- Granulosa cell tumors and adolescent physiology are important non-PCOS causes to rule out, especially when AMH is dramatically elevated or the clinical picture doesn't fit PCOS.
- Lifestyle interventions work: low-glycemic diet, resistance training, and vitamin D repletion each have mechanistic and clinical evidence for reducing PCOS-driven AMH elevation.
- IVF outcomes in PCOS are not automatically superior despite high egg counts — egg quality and insulin status matter more than the AMH number for live birth rates.
- Supplementing for high AMH means targeting the drivers — insulin signaling, inflammation, and androgen metabolism — not the biomarker itself.
---
Always consult a qualified healthcare provider or reproductive endocrinologist before making changes to your supplement regimen or treatment plan based on AMH results.